GGHC
Gilder Gagnon Howe & Co Portfolio holdings
AUM
$9.42B
This Quarter Return
+3.93%
1 Year Return
+54.36%
3 Year Return
+272.74%
5 Year Return
+377.85%
10 Year Return
+3,143.71%
AUM
$5.36B
AUM Growth
+$5.36B
(-6.5%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-1.89%
Top 10 Holdings %
Top 10 Hldgs %
30.29%
Holding
272
New
25
Increased
53
Reduced
155
Closed
28
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$79.4M |
| 2 |
Meta Platforms (Facebook)
META
|
$51.1M |
| 3 |
Chart Industries
GTLS
|
$32.8M |
| 4 |
Wolfspeed
WOLF
|
$23.4M |
| 5 |
Madison Square Garden
MSGS
|
$23.2M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$53.7M |
| 2 |
Enphase Energy
ENPH
|
$35M |
| 3 |
Calix
CALX
|
$30.1M |
| 4 |
LFG
Archaea Energy Inc.
LFG
|
$29.8M |
| 5 |
Tesla
TSLA
|
$22.8M |
Sector Composition
| 1 | Technology | 32.99% |
| 2 | Healthcare | 19.84% |
| 3 | Consumer Discretionary | 17.94% |
| 4 | Industrials | 9.84% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Bristow Group
VTOL
$1.11B
| $300K | 0.01% |
+11,074
| New | +$300K |
|
227
Avidity Biosciences
RNA
$5.99B
| $298K | 0.01% |
+13,444
| New | +$298K |
|
228
Endava
DAVA
$873M
| $287K | 0.01% |
3,746
-5,523
| -60% | -$423K |
|
|
NEX
229
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $285K | 0.01% |
30,829
-410
| -1% | -$3.79K |
|
|
ENFN
230
DELISTED
Enfusion, Inc.
ENFN
| $280K | 0.01% |
28,946
+172
| +0.6% | +$1.66K |
|
|
VZLA
231
Vizsla Silver
VZLA
$1.26B
| $278K | 0.01% |
241,903
-1,127,240
| -82% | -$1.3M |
|
232
Shenandoah Telecom
SHEN
$727M
| $267K | 0.01% |
16,796
-346
| -2% | -$5.49K |
|
233
BridgeBio Pharma
BBIO
$9.89B
| $248K | ﹤0.01% |
32,539
-15,861
| -33% | -$121K |
|
|
VIRX
234
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $236K | ﹤0.01% |
161,507
-100
| -0.1% | -$146 |
|
235
Credo Technology Group
CRDO
$21.5B
| $230K | ﹤0.01% |
17,275
-6
| -0% | -$80 |
|
236
Stoke Therapeutics
STOK
$1.07B
| $209K | ﹤0.01% |
22,604
-35,260
| -61% | -$325K |
|
237
Remitly
RELY
$3.82B
| $208K | ﹤0.01% |
18,158
-51
| -0.3% | -$584 |
|
|
PRVB
238
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $199K | ﹤0.01% |
+18,842
| New | +$199K |
|
239
Eventbrite
EB
$256M
| $172K | ﹤0.01% |
29,301
| – | – |
|
240
UiPath
PATH
$5.83B
| $159K | ﹤0.01% |
12,525
-17,424
| -58% | -$221K |
|
241
Fathom Holdings
FTHM
$56M
| $141K | ﹤0.01% |
33,194
-22,006
| -40% | -$93.5K |
|
242
Torrid Holdings
CURV
$216M
| $132K | ﹤0.01% |
44,641
| – | – |
|
243
Compass
COMP
$4.77B
| $110K | ﹤0.01% |
47,326
| – | – |
|
|
RDFN
244
DELISTED
Redfin
RDFN
| $81.7K | ﹤0.01% |
19,266
| – | – |
|
245
Arteris
AIP
$402M
| – | – |
-601,264
| Closed | -$4M |
|
246
Alector
ALEC
$238M
| – | – |
-24,703
| Closed | -$234K |
|
247
Aurinia Pharmaceuticals
AUPH
$1.58B
| – | – |
-179,090
| Closed | -$1.35M |
|
248
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-303,642
| Closed | -$3.83M |
|
249
Core & Main
CNM
$12.3B
| – | – |
-229,995
| Closed | -$5.23M |
|
250
Dianthus Therapeutics
DNTH
$759M
| – | – |
-705,217
| Closed | -$994K |
|